MarketFriction

Tejnaksh Healthcare Ltd

BSE 539428 · Healthcare Service Provider
₹12.54 -4.27%
BSE close2026-10-01
Market cap₹25.8 Cr.
P/E20.8

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3.093.142.923.123.373.193.212.642.982.622.552.65
Expenses1.962.072.012.042.212.052.502.042.211.931.841.96
Operating Profit1.131.070.911.081.161.140.710.600.770.690.710.69
OPM %36.57%34.08%31.16%34.62%34.42%35.74%22.12%22.73%25.84%26.34%27.84%26.04%
Other Income0.080.070.070.070.090.170.070.090.090.070.140.10
Interest0.160.190.140.120.110.140.010.050.030.04-0.030.01
Depreciation0.230.230.230.230.310.200.170.360.350.360.360.35
Profit before tax0.820.720.610.800.830.970.600.280.480.360.520.43
Tax %26.83%25.00%26.23%25.00%21.69%42.27%28.33%28.57%33.33%19.44%32.69%37.21%
Net Profit0.610.540.460.600.650.560.420.210.330.280.350.26
EPS in Rs0.290.270.250.300.310.300.250.120.150.150.180.13
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4.757.2814.1419.7617.1211.9612.6811.7312.1812.7510.5410.80
Expenses2.454.088.8015.5813.088.247.888.038.558.657.747.94
Operating Profit2.303.205.344.184.043.724.803.703.634.102.802.86
OPM %48.42%43.96%37.77%21.15%23.60%31.10%37.85%31.54%29.80%32.16%26.57%26.48%
Other Income0.030.190.391.550.340.130.110.310.310.400.380.40
Interest0.000.200.980.780.760.500.480.620.660.400.110.05
Depreciation0.210.350.470.590.650.680.670.870.910.911.431.42
Profit before tax2.122.844.284.362.972.673.762.522.373.191.641.79
Tax %37.74%32.75%25.70%28.21%27.61%22.47%25.27%28.57%25.74%30.09%28.05%
Net Profit1.321.823.183.142.152.072.811.791.772.231.181.22
EPS in Rs0.650.901.421.491.031.011.340.830.881.150.610.61
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth8%-3%-4%-13%
Compounded Profit Growth-1%-10%-10%-38%
Stock Price CAGR2%-21%-26%-28%
Return on Equity13%9%7%5%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital1.102.212.2110.1610.1610.1610.1610.1610.1610.1610.16
Reserves5.145.867.933.005.097.169.9011.6113.4115.7516.99
Borrowings0.006.397.646.337.194.896.996.424.801.050.25
Other Liabilities0.601.071.982.782.472.362.563.042.993.352.65
Total Liabilities6.8415.5319.7622.2724.9124.5729.6131.2331.3630.3130.05
Fixed Assets3.3413.6015.3316.9717.3715.0415.3823.4223.2221.1620.23
CWIP0.000.000.000.390.650.798.890.951.071.331.69
Investments2.590.010.000.000.000.000.000.000.000.000.00
Other Assets0.911.924.434.916.898.745.346.867.077.828.13
Total Assets6.8415.5319.7622.2724.9124.5729.6131.2331.3630.3130.05
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3.672.254.493.151.161.189.212.124.010.241.72
Cash from Investing Activity-3.26-8.03-3.24-1.55-1.211.56-10.59-1.40-1.013.66-0.28
Cash from Financing Activity-0.136.43-0.66-2.090.10-2.801.62-1.20-2.27-3.87-1.24
Net Cash Flow0.290.650.59-0.500.05-0.060.24-0.480.730.030.19
Free Cash Flow2.99-8.363.001.58-0.152.680.091.193.181.121.21
CFO/OP160%70%104%94%41%13%187%46%120%17%91%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days0.000.00-0.773.5111.3014.3416.4149.1615.5852.9675.49
Inventory Days98.06130.36220.84254.58179.69283.89185.07173.44232.80223.53297.01
Days Payable114.40225.95226.97184.03151.62190.61100.25139.7963.2384.8885.88
Cash Conversion Cycle-16.34-95.60-6.9174.0639.38107.62101.2382.82185.15191.60286.62
Working Capital Days-1.544.51-42.8519.4075.478.556.6244.503.3081.8791.77
ROCE %29.19%32.23%27.11%17.45%13.97%17.03%11.13%10.48%12.71%6.35%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.83%73.83%73.83%73.83%73.83%73.83%73.83%73.83%73.83%73.83%73.83%73.83%
FIIs0.58%0.58%0.28%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public25.58%25.60%25.89%26.17%26.16%26.17%26.17%26.16%26.17%26.17%26.16%26.16%
No. of Shareholders2,6283,0573,5023,7764,0674,4964,4934,5524,5504,4524,4144,395

Fundamentals

Market Cap₹ 25.8 Cr.
Current Price₹ 12.7
Stock P/E20.8
Book Value₹ 13.4
ROCE6.35 %
ROE4.67 %
Dividend Yield0.00 %
Face Value₹ 5.00
Compounded Sales Growth (TTM)-13%
Compounded Profit Growth (TTM)-38%
Consolidated figures.
Valuation
Market capRs 25 Cr
Enterprise valueRs 24 Cr
P/E (TTM)20.54x
Price to book0.94x
Price to sales2.36x
EV / EBITDA7.27x
EV / EBIT12.88x
EV / sales2.19x
Price to cash flow14.81x
Earnings yield4.87%
P/E, 3-year average21.48x
P/B, 3-year average1.51x
P/E, 5-year average23.34x
P/B, 5-year average2.08x
Profitability
Operating margin (excl. other income)26.57%
Operating margin (incl. other income)30.17%
EBITDA margin30.19%
Pre-tax margin16.57%
Net profit margin11.48%
Net margin, latest quarter10.19%
ROE4.64%
ROCE6.44%
ROA4.08%
ROE, 3-year average7.30%
ROCE, 3-year average10.04%
ROA, 3-year average5.77%
ROE, 5-year average8.90%
ROCE, 5-year average11.74%
ROA, 5-year average6.58%
ROIC (approx.)5.22%
Tax rate28.05%
Other income / net worth1.40%
Growth
Sales growth (latest year)-17.33%
Profit growth (latest year)-47.21%
Sales CAGR, 3 years-3.50%
Sales CAGR, 5 years-2.50%
Profit CAGR, 3 years-9.87%
Profit CAGR, 5 years-9.71%
Sales growth QoQ3.92%
Profit growth QoQ-25.00%
Sales growth YoY (latest quarter)0.38%
Profit growth YoY (latest quarter)8.00%
Per share
EPS (TTM)Rs 0.61
EPS (latest year)Rs 0.61
EPS (latest quarter)Rs 0.13
EPS, 3-year averageRs 0.88
EPS, 5-year averageRs 1.39
Book value per shareRs 13.37
Sales per shareRs 5.32
Cash flow per shareRs 0.85
Free cash flow per shareRs 0.60
Efficiency
Asset turnover0.35x
Fixed asset turnover0.52x
Inventory turnover3.34x
Inventory days109 days
Debtor days75 days
Debtors turnover4.83x
Creditor days86 days
Cash conversion cycle287 days
Working capital days92 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 2 Cr
Net debtRs -2 Cr
Debt to equity0.01x
Net debt / EBITDA-0.55x
Interest coverage36.80x
Owners' fund to total sources90.35%
Debt to assets0.83%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Cash from ops / profit, 5 years1.77x
Sales to cash flow6.13x
Statement figures
Net sales (TTM)Rs 11 Cr
Net sales (latest year)Rs 11 Cr
Sales (latest quarter)Rs 3 Cr
Operating profit excl. other income (latest year)Rs 3 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 3 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 8 Cr
Total income (latest year)Rs 11 Cr
Share capitalRs 10 Cr
ReservesRs 17 Cr
Shareholders' fundsRs 27 Cr
Total assetsRs 30 Cr
Net blockRs 20 Cr
Capital work in progressRs 2 Cr
ReceivablesRs 2 Cr
InventoryRs 1 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)2.03
Ownership
Promoter holding73.83% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 20.5 is at the 27th percentile of its own 9.4-year range (median 27.9, low 12.4, high 87.9).
P/B 0.94 is the lowest in 9.4 years (median 3.70).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period539428Nifty 50Difference
1 week-4.3%-2.8% -1.6 pts
1 month-10.4%-6.8% -3.6 pts
3 months-15.1%-7.6% -7.5 pts
3 years-61.8%+14.2% -76.0 pts
5 years-71.7%+27.9% -99.6 pts

Red flags

F-score 5 of 8
explainReceivables outrunning sales Receivables grew 18% vs sales -17% in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹3 Cr +0.4% vs Jun 2025. Net profit ₹0 Cr +23.8%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Tejnaksh Healthcare Ltd?

Tejnaksh Healthcare Ltd (539428) has a market capitalisation of Rs 25.8 Cr. at the 2026-10-01 close.

What is the P/E ratio of Tejnaksh Healthcare Ltd?

Tejnaksh Healthcare Ltd trades at a P/E of 20.8 on trailing twelve-month profit, at the 2026-10-01 close.

What were Tejnaksh Healthcare Ltd's latest quarterly results?

In the Jun 2026 quarter, Tejnaksh Healthcare Ltd sales was Rs 3 Cr (+0.4% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03